Navigation Links
The Skinny on Teen Surgery
Date:10/1/2007

FDA to approve gastric band for adolescents by 2009

WALTHAM, Mass., Oct. 1 /PRNewswire/ -- Millennium Research Group forecasts that the gastric band market, currently valued at over $190 million, will exceed $630 million by 2012. The expected 2009 FDA approval of the LAP-BAND device for adolescents aged 14 to 18 will significantly expand the potential patient base into one of the most rapidly growing segments of the obese population, according to Millennium Research Group's US Markets for Laparoscopic Devices 2008 report.

The two surgical approaches to obesity, laparoscopic adjustable gastric banding (LAGB)-which uses devices such as Allergan's LAP-BAND-and gastric bypass surgery, primarily involve restricting food intake into the stomach, thereby limiting caloric intake. A LAGB procedure involves the placement of an adjustable gastric band around the upper part of the stomach, while gastric bypass surgery changes the anatomy of the digestive system to limit the amount of food that can be eaten and digested. Gastric bypass surgery may currently be performed on adolescents because it does not need FDA approval. Promoters of LAGB point to lower risk of life-threatening complications, adjustability, and reversibility which will encourage further penetration of LAGB procedures among adolescent patients.

"There has been an alarming growth in the number of obese adolescents in the US," says Barbara Prud'homme, Senior Analyst at MRG. "The approval of the LAP-BAND for adolescents will provide an additional option to treat these younger patients. The FDA stamp of approval of the LAP-BAND will likely make LAGB performed at an increasing rate by doctors."

The US Markets for Laparoscopic Devices 2008 report includes coverage of industry competitors including Allergan, Ethicon Endo-Surgery, Covidien, Stryker, Applied Medical, and Karl Storz.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Skinny people need to exercise too
2. Spain Launches Movement Against Skinny Fashion Models
3. Skinny Debate Upsets Actress Knightley
4. Skinny Girl-bands are Making Detrimental Impact on Teenage Girls
5. Skinny Debate Upsets Actress Knightley
6. Cox Cringes Seeing Her Skinny Friends Body!
7. No Progress in France on skinny Model Charter
8. Too Skinny Models Banned from Performing in Rome Fashion Show
9. Bypass Heart Surgery Performed Without General Anesthesia
10. NEW ROBOTIC SURGERY ARM APPROVED BY FDA
11. Thyroid hormone treatment hastens recovery after cardiac surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which ... nutrients from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... the body recognizes its raw form (unlike the synthetically made options that are on ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical technology company ... has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for ... Both devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental ... with dental fear and require sedation to receive dental care. The doctors offer three ... procedures, from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
(Date:4/18/2017)... Viverae ® , a leader in workplace wellness technology, ... Watson Campaign Automation, implementing behavioral messaging within the ... experience. Through digital engagement, the platform prompts members to ... The enhanced experience drives engagement by focusing on the ... in their journey to health. Unlike ...
Breaking Medicine Technology: